Loomis, Sayles & Company’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Loomis, Sayles & Company’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-195,677	Closed	-$8.07M	–	1111
2015 Q2	$8.07M	Sell	195,677 -100,645	-34%	-$3.61M	0.02%	488
2015 Q1	$10.4M	Sell	296,322 -3,625	-1%	-$123K	0.03%	481
2014 Q4	$9.64M	Sell	299,947 -5,452	-2%	-$158K	0.03%	504
2014 Q3	$8.57M	Sell	305,399 -1,278	-0.4%	-$38.9K	0.03%	506
2014 Q2	$9.27M	Sell	306,677 -104,083	-25%	-$2.87M	0.03%	511
2014 Q1	$11.4M	Sell	410,760 -11,138	-3%	-$291K	0.03%	480
2013 Q4	$10.8M	Sell	421,898 -126,041	-23%	-$3.88M	0.03%	487
2013 Q3	$16.4M	Sell	547,939 -3,036	-0.6%	-$84.4K	0.05%	401
2013 Q2	$15.8K	Buy	+550,975	New	+$15.2M	0.06%	374

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Loomis, Sayles & Company's BRLI Position: Q3 2015 in Review

Loomis, Sayles & Company sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 195,677 shares — an estimated $8.07M sold.

Loomis, Sayles & Company first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $16.4M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Loomis, Sayles & Company reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Loomis, Sayles & Company sold 195,677 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $8.07M.
Loomis, Sayles & Company first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Loomis, Sayles & Company's BIO-REFERENCE LABS INC-NEW- position peaked at $16.4M in Q3 2013.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Loomis, Sayles & Company's 13F filing for Q3 2015, filed 13 Nov 2015.